ETPrime

Colinz Labs - Colinz Laboratories Share Price

  • 42.79-0.21 (-0.48%)
  • Volume: 1,044
BSE
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:30 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Colinz Labs - Colinz Laboratories Share Price
  • 42.79-0.21 (-0.48%)
  • Volume: 1,044
Advertisment

Colinz Labs share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 43.5% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Colinz Laboratories Ltd. share price moved down by -0.48% from its previous close of Rs 43.00. Colinz Laboratories Ltd. stock last traded price is 42.79

    Share PriceValue
    Today/Current/Last-42.79
    Previous Day-43.00

InsightsColinz Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		22.52
    EPS - TTM
    (₹)    		1.90
    MCap
    (₹ Cr.)    		10.78
    Sectoral MCap Rank
    		168
    PB Ratio
    (x)    		1.14
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.12
    3 Months-0.49
    6 Months-0.36
    1 Year-0.01
    3 Years0.00

    		-0.12
    VWAP
    (₹)    		41.33
    52W H/L
    (₹)
    88.70 / 37.87

    Colinz Labs Share Price Returns

    1 Day-0.48%
    1 Week2.49%
    1 Month-2.64%
    3 Months-30.23%
    1 Year-29.18%
    3 Years-0.95%
    5 Years430.89%

    ET Stock ScreenersTop Score Companies

    Check whether Colinz Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Colinz Labs News & Analysis

    View all Colinz Labs Share News & Announcements

    Colinz Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Colinz Labs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Colinz Labs Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 43.5% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income1.641.531.541.941.81
      Total Income Growth (%)7.49-1.09-20.457.004.46
      Total Expenses1.471.391.441.721.62
      Total Expenses Growth (%)5.86-3.31-16.616.245.39
      EBIT0.170.140.110.220.19
      EBIT Growth (%)23.6928.15-50.5513.30-2.66
      Profit after Tax (PAT)0.120.150.050.160.14
      PAT Growth (%)-20.74182.18-65.7713.480.88
      EBIT Margin (%)10.509.127.0411.3310.70
      Net Profit Margin (%)7.269.853.458.027.56
      Basic EPS (₹)0.470.600.210.620.54
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue6.837.307.337.156.35
      Total Revenue Growth (%)-6.56-0.312.5512.52-17.94
      Total Expenses6.216.656.736.666.10
      Total Expenses Growth (%)-6.73-1.080.949.17-19.27
      Profit after Tax (PAT)0.500.490.460.340.21
      PAT Growth (%)2.036.4134.8163.4659.13
      Operating Profit Margin (%)10.139.789.117.965.38
      Net Profit Margin (%)7.606.926.394.863.37
      Basic EPS (₹)1.971.931.820.740.99

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets11.8211.3610.239.9310.09
      Total Assets Growth (%)4.0511.053.02-1.5914.53
      Total Liabilities2.342.412.092.242.80
      Total Liabilities Growth (%)-2.9015.31-6.70-20.0042.13
      Total Equity9.478.958.147.697.29
      Total Equity Growth (%)5.819.955.855.496.58
      Current Ratio (x)4.174.004.153.722.82
      Total Debt to Equity (x)0.070.060.030.060.14
      Contingent Liabilities0.000.090.2824,367.230.25

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-1.451.030.400.472.16
      Net Cash used in Investing Activities0.050.010.01-0.03-0.15
      Net Cash flow from Financing Activities-0.040.230.110.090.08
      Net Cash Flow-1.451.270.520.522.08
      Closing Cash & Cash Equivalent5.557.005.735.214.68
      Closing Cash & Cash Equivalent Growth (%)-20.7122.1910.0411.2180.20
      Total Debt/ CFO (x)-0.440.550.681.040.46

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)5.245.435.614.412.84
      Return on Capital Employed (%)6.857.497.816.994.41
      Return on Assets (%)4.204.284.473.412.05
      Interest Coverage Ratio (x)18.7021.9814.9310.033.83
      Asset Turnover Ratio (x)0.560.650.710.7061.04
      Price to Earnings (x)36.7619.4619.3124.6313.00
      Price to Book (x)1.931.061.081.090.37
      EV/EBITDA (x)16.823.704.304.79-3.00
      EBITDA Margin (%)12.1411.6310.9110.855.38

      No reported Financial Ratios are available.

    Financial InsightsColinz Labs

    • Income (P&L)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 43.5% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Colinz Labs Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Colinz Labs Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Colinz Labs22.521.145.246.854.20-1.5010.137.601.974.170.07-0.44
          Norris Medicine-13.55-1.080.00-20.17-8.96-14.53-12.68-21.26-1.240.62-1.4572.30
          Parmax Pharma-4.68-6.750.00-12.90-11.1615.37-2.61-7.42-5.600.77-3.87-11.74
          Beryl Drugs54.301.336.0911.963.6215.006.592.731.142.100.431.54
          Unjha Form115.553.5612.9816.918.94-0.873.832.930.912.370.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Ortin Labs
          • Kamron Labs.
          • Vivanza Biosciences
          • Brawn Biotech
          • Shyama Infosys

          Choose from Stocks

            See All Parameters

          Peers InsightsColinz Labs

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Colinz Labs Shareholding Pattern

            • Loading...
              Showing Colinz Labs Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters66.0066.0066.0066.00
              Pledge0.000.000.000.00
              FII0.000.000.000.00
              DII0.000.000.000.00
              Mutual Funds0.000.000.000.00
              Others34.0034.0034.0034.00
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters16,62,65966.00 %0.00
              Pledge00.00 %0.00
              Others8,56,44134.00 %0.00

            Colinz Labs MF Ownership

            MF Ownership details are not available.

            Top Searches:
            Colinz Labs News Colinz Labs Quarterly Results Colinz Labs Dividend Colinz Labs Q1 ResultsColinz Labs Q2 ResultsColinz Labs Q3 ResultsColinz Labs Q4 Results

            Colinz Labs Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Sep 30, 2025Aug 26, 2025AGM-
              Jul 31, 2025Jul 14, 2025Board MeetingQuarterly Results
              May 16, 2025May 07, 2025Board MeetingAudited Results
              Jan 31, 2025Jan 13, 2025Board MeetingQuarterly Results
              Oct 30, 2024Oct 14, 2024Board MeetingQuarterly Results

            • Dividend announcements are not available.

            • No other corporate actions details are available.

            About Colinz Labs

            Colinz Laboratories Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 10.78 Crore) operating in Pharmaceuticals sector. Colinz Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • NK

              N K Menon

              Whole Time Director
              ML

              Mani L S

              Non Executive Director
              AK

              A Krishna Kumar

              Independent Director
              VK

              Vasant K Bhat

              Independent Director
              Show More
            • Vora & Associates
              Sanjay R Dholakia
              S V Bhat & Co

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            A-101, Pratik Ind.Estate,Mulund-Goregaon Link Road,Bhandup (W),Mumbai, Maharashtra - 400078

            Contact

            colinzlabs@yahoo.com

            http://www.findoc-cll.in

            More Details

            FAQs about Colinz Labs share

            • 1. What is Colinz Labs share price and what are the returns for Colinz Labs share?
              Colinz Labs share price is Rs 42.79 as on 08 Sep, 2025, 03:30 PM IST. Colinz Labs share price is down by 0.48% based on previous share price of Rs. 42.79.
            • 2. What is the PE & PB ratio of Colinz Labs?
              The PE ratio of Colinz Labs stands at 22.63, while the PB ratio is 1.14.
            • 3. What are the returns for Colinz Labs share?
              Return Performance of Colinz Labs Shares:
              • 1 Week: Colinz Labs share price moved up by 2.49%
              • 3 Month: Colinz Labs share price moved down by 30.23%
              • 6 Month: Colinz Labs share price moved down by 13.42%
            • 4. What is Colinz Labs's 52 week high / low?
              Colinz Labs share price saw a 52 week high of Rs 88.70 and 52 week low of Rs 37.87.
            • 5. What's the market capitalization of Colinz Labs?
              Market Capitalization of Colinz Labs stock is Rs 10.78 Cr.

            Trending in Markets

            Top Gainers As on 03:59 PM | 08 Sep 2025

            Suven Pharma 1,012.95
            90.06 (9.76%)
            Guj Mineral Dev.539.15
            30.15 (5.93%)
            Bharat Forge1,202.80
            66.10 (5.82%)
            Ashok Leyland137.29
            6.52 (4.99%)
            JP Power20.02
            0.95 (4.99%)

            Top Losers As on 03:57 PM | 08 Sep 2025

            Amber Enterprises7,473.00
            -320.50 (-4.12%)
            EID Parry1,067.30
            -45.50 (-4.09%)
            Trent5,315.50
            -213.00 (-3.86%)
            Godfrey Philips10,657.00
            -416.00 (-3.76%)
            Coromandel Int.2,185.20
            -72.71 (-3.22%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Colinz Labs Share Price
            The Economic Times
            BrowseCompanies: